Imagine a molecular container where the building blocks are glued together with a substance that’s sensitive to glucose: when glucose levels…
Tag: Smart Insulin
JDRF, partnered with Sanofi, the company that manufactures Lantus among other insulins, recently pledged up to $4.6 million to support research into four different efforts to design a glucose-responsive insulin.
Researchers at MIT successfully tested an engineered “smart insulin” on mice that reacts to blood sugar levels.
“To make insulin that is…
In 2003, an MIT chemical engineer founded a company called SmartCells, to develop smart insulin.
Smart insulin is a form of insulin that circulates in the bloodstream and turns on when it’s needed to lower blood sugars and off when blood sugars are at safe levels.
The Juvenile Diabetes Research Foundation (JDRF) and InnoCentive, Inc., the pioneer in open innovation and crowdsourcing, announced a $100,000 Challenge calling for innovative ways to approach the discovery and development of a glucose-responsive insulin drug as a means to treat insulin-dependent diabetes. The Challenge is open to the public and can be found on the InnoCentive website...
Scientists from Biodel Inc. reported new findings from the company's Linjeta™, insulin glargine, "smart" basal insulin and stabilized glucagon development programs in poster presentations at the Tenth Annual Diabetes Technology Meeting in Bethesda, MD...
Biodel Inc. reported results of preclinical tests which demonstrated the potential of the company's glucose-regulated or "smart" basal insulin product candidate, BIOD620, to release insulin proportionally in response to changing glucose conditions. In an oral presentation today at the 37th Annual Meeting and Exposition of the Controlled Release Society in Portland...